We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Emapalumab Shows Promise As Targeted Therapy for Children Fighting Deadly Immune Disease

News   May 07, 2020 | Original story from Cincinnati Children's

 
Emapalumab Shows Promise As Targeted Therapy for Children Fighting Deadly Immune Disease

A laboratory technician at Cincinnati Children's conducts immunology testing for the severe childhood immune disorder HLH (hemophagocytic lymphohistiocytosis), which damages vital organs and tissues. Researchers report in the New England Journal of Medicine treating patients with a new drug that saved kid's lives with less toxicity and fewer side effects. Doctors hope the treatment will help dent HLH's high mortality rate. Credit: Cincinnati Children's

 
 
Advertisement
 

RELATED ARTICLES

Mutated Form of SARS-CoV-2 is Dominant, But Doesn't Make Patients Sicker, Study Says

News

In a collaborative research study, scientists show that a mutated version of SARS-CoV-2 has become the predominant form across the globe. Whilst the variant competes with the original strain, clinical data suggests that it does not make individuals sicker.

READ MORE

Oat and Rye Bran Boost Gut Microbiome and Benefit Health

News

Consumption of dietary fiber from oat and rye brans supported the growth of beneficial gut microbiota, which in turn benefited cholesterol levels, weight gain, liver inflammation and gut health.

READ MORE

Safer and More Efficient Method To Deliver Gene Therapy

News

Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE